Asymptomatic shedding of herpes simplex virus 1 and 2: Implications for prevention of transmission

Journal of Infectious Diseases

Volumn 198, Issue 8, 2008, Pages 1098-1100

  Mertz, Gregory J ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; FAMCICLOVIR; HERPES SIMPLEX VACCINE; IMMUNOMODULATING AGENT; RESIQUIMOD; VALACICLOVIR;

ADD ON THERAPY; ANTIVIRAL THERAPY; CLINICAL TRIAL; CONDOM; DRUG MEGADOSE; EDITORIAL; GENITAL HERPES; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION PREVENTION; INFECTION RISK; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK MANAGEMENT; SEXUAL TRANSMISSION; VIRUS CULTURE; VIRUS ISOLATION; VIRUS LOAD; VIRUS SHEDDING; VIRUS TRANSMISSION;

ADULT; ANTIBODIES, VIRAL; DNA, VIRAL; FEMALE; GENITALIA; HERPES GENITALIS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; MALE; MOUTH MUCOSA; POLYMERASE CHAIN REACTION; VIRUS ACTIVATION; VIRUS SHEDDING;

EID: 54749106513     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/591914     Document Type: Editorial

References (40)

1. Cone RW, Hobson AC, Palmer J, Remington M, Corey L. Extended duration of herpes simplex virus DNA in genital lesions by the polymerase chain reaction. J Infect Dis 1991; 164:757-60.
2. Wald A , Zeh J, Selke S, Ashley RL, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995; 333:770-5.
3. Mertz GJ, Schmidt O, Jourden J, et al. Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sex Transm Dis 1985; 12:33-9.
4. Rooney JJ, Falger JM, Ostrove JM, Straus SE. Acquisition of genital herpes from an asymptomatic sexual partner. N Engl J Med 1986; 314:1561-4.
5. Yeager AS, Arvin AM. Reasons for the absence of a history of recurrent genital infections in mothers of neonates infected with herpes simplex virus. Pediatrics 1984; 73:188-93.
6. Whitley RJ, Nahmias AJ, Visintine AM, Fleming CL, Alford CA. The natural history of herpes simplex infection of mother and newborn. Pediatrics 1980; 66:489-94.
7. Brock BV, Selke S, Benedetti J, Douglas JM Jr, Corey L. Frequency of asymptomatic shedding of herpes simplex virus in women with genital herpes. JAMA 1990; 263:418-20.
8. Rattray MD, Corey L, Reeves WC, Vontver WC, Holmes KK. Recurrent genital herpes among women: symptomatic v. asymptomatic viral shedding. Br J Vener Dis 1978; 54:262-5.
9. Deture FA, Drylie DM, Kaufman HE, Centifano YM. Herpesvirus type 2: study of semen in male subjects with recurrent infections. J Urol 1978; 120:449-51.
10. Mertz G, Corey L. Genital herpes simplex virus infections in adults. Urol Clin North Am 1984; 11:103-19.
11. Mertz GJ, Benedetti J, Ashley R, Selke SA, Corey L. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992; 116:197-202.
12. Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J. Frequent genital herpes virus 2 shedding in immunocompetent women: effect of acyclovir treatment. J Clin Invest 1997; 99:1092-7.
13. Koelle DM, Benedetti J, Langenberg A, Corey L. Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes. Ann Intern Med 1992; 116:433-7.
14. Krone MR, Wald A, Tabet SR, Paradise M, Corey L, Celum CL. Herpes simplex virus type 2 shedding in HIV-negative men who have sex with men: frequency, patterns, and risk factors. Clin Infect Dis 2000; 30:261-7.
15. Wald A, Zeh J, Selke S, Warren T, Ashley R, Corey L. Genital shedding of herpes simplex virus among men. J Infect Dis 2002; 186(Suppl 1):S34-9.
16. Gupta R, Wald A, Krantz E, et al. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract. J Infect Dis 2004; 190:1374-81.
17. Corey L, Wald A, Patel R, et al. Once daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004; 350:11-20.
18. Wald A, Matson P, Ryncarz A, Corey L. Detection of herpes simplex virus DNA in semen of men with genital HSV-2 infection. Sex Transm Dis 1999; 26:1-3.
19. Wald A, Selke S, Warren T, et al. Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding. Sex Transm Dis 2006; 33:529-33.
20. Wald A, Langenberg AG, Krantz E, et al. The relationship between condom use and herpes simplex virus acquisition. Ann Intern Med 2005; 143:707-13.
21. Crespi CM, Cumberland WG, Blower S. A queueing model for chronic recurrent conditions under panel observation. Biometrics 2005; 61:193-8.
22. Crespi CM, Cumberland WG, Wald A, Corey L, Blower S. Longitudinal study of herpes simplex virus type 2 infection using viral dynamic modelling. Sex Transm Infect 2007; 83:359-64.
23. + T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation. J Exp Med 2007; 204:595-603.
24. Mark KE, Wald A, Margaret AS, et al. Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults. J Infect Dis 2008; 198:1141-9 (in this issue).
25. Mark KE, Corey L, Meng T-C, et al. Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial. J Infect Dis 2007; 195:1324-31.
26. Crute JJ, Grygon CA, Hargrave KD, et al. Herpes simplex virus helicase-primase inhibitors are active in animal models of human diseases. Nature Med 2002; 8:386-91.
27. Reynolds SJ, Quinn TC. Developments in STD/HIV interactions: the intertwining epidemics of HIV and HSV-2. Infect Dis Clin North Am 2005; 19:415-25.
28. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex type 2-seropositive persons: a meta-analysis. J Infect Dis 2002; 185:45-52.
29. Reynolds SJ, Risbud AR, Shepherd ME, et al. Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India. J Infect Dis 2003; 187:1513-21.
30. Watson-Jones D, Weiss HA, Rusizoka M, et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med 2008; 358:1560-71.
31. + T cells specific for a skin-tropic virus. J Clin Invest 2002; 110:537-48.
32. Mosca J, Bednarik D, Raj N, et al. Herpes simplex virus type 1 can reactivate transcription of latent human immunodeficiency virus. Nature 1987; 325:67-70.
33. Margolis D, Ostrove J, Straus S. HIV-1 activation of HIV-1 transcription is augmented by a cellular protein that binds near the initiator element. Virology 1993; 192:370-4.
34. Golden MP, Kim S, Hammer SM, et al. Activation of human immunodeficiency virus by herpes simplex virus. J Infect Dis 1992; 166:494-9.
35. Mole L, Ripich S, Margolis D, Holodniy M. The impact of active herpes simplex virus infection on human immunodeficiency virus load. J Infect Dis 1997; 176:766-70.
36. Nagot N, Quedraogo A, Foulongne V, et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med 2007; 356:790-9.
37. Ioannidis JPA, Collier AC, Cooper DA, et al. Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data. J Infect Dis 1998; 178:349-59.
38. Cooper DA, Pehrson O, Pedersen C, et al. The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex: a double-blind, randomized trial. AIDS 1993; 7:197-207.
39. Schacker T, Zeh J, Hu H, Shaughnessy, Corey L. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. J Infect Dis 2002; 186:1718-25.
40. Zuckerman RA, Lucchetti A, Whittington WLH, et al. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, doubleblind, placebo-controlled crossover trial. J Infect Dis 2007; 196:1500-8.